FUNDAMENTALS · Fundamentals · TW Healthcare

AnnJi (7754) Fundamentals 2026 — Revenue Analysis | SniperIQ

AnnJi (7754) is a TW-listed Healthcare company in Biotechnology with a market capitalization of NT$5.7B, trading at NT$57.00 on the TWO. This SniperIQ fundamentals page covers AnnJi's valuation, profitability (net margin -4738.7%), revenue (NT$8M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Market CapNT$5.7B
Net Margin-4738.7%
Revenue (FY25)NT$8M

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is AnnJi's market cap?

AnnJi (7754) has a market capitalization of approximately NT$5.7B, trading at NT$57.00 on the TWO. Market cap moves with the live share price.

What is AnnJi's P/E ratio?

AnnJi's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 16.9x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is AnnJi?

AnnJi runs a net profit margin of -4738.7%, a gross margin of -282.1%, and an operating margin of -180.4%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does AnnJi generate?

AnnJi reported revenue of NT$8M for fiscal year 2025, with net income of -NT

58M and earnings per share (EPS) of -3.78. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does AnnJi pay a dividend?

AnnJi does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.

Is AnnJi financially healthy?

AnnJi carries a debt-to-equity ratio of 0.15x and a current ratio of 3.60x, with a market beta of -0.39. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is AnnJi a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For AnnJi (7754) the key facts are: market cap NT$5.7B, revenue NT$8M, 52-week range 31.2-71.2. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.

Track AnnJi's full fundamentals live

Get AnnJi's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.